BackJasper Therapeutics Overview

Jasper Therapeutics Total Current Liabilities

Jasper Therapeutics's total current liabilities is $9M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$9.00M
27.06% YoYΔ $-3.34M vs prior year quarter

Peer average

Loading

Jasper Therapeutics Total Current Liabilities History

Loading

Jasper Therapeutics vs. peers: Total Current Liabilities Comparison

Loading

Jasper Therapeutics Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Jasper Therapeutics (JSPR) FAQ

As of the most recent data (March 2026), JSPR shows a total current liabilities of $9M. That compares with $12M in the prior-year period — down 27.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JSPR's total current liabilities is now $9M (was $12M) — a 27.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Jasper Therapeutics is outperforming or lagging.

Tracking JSPR's total current liabilities over time shows whether Jasper Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $9M That compares with $12M in the prior-year period — down 27.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Jasper Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $9M) with ownership activity and broader fundamentals.